Sign in / Sign up

← Back to companies

Genesis Molecular AI（原Genesis Therapeutics）

Market cap / valuation—

Total funding≥$280M

Last financing / listing2023-08-21

Last round

Series B · 2023-08-21

$200M

The date is the latest verified disclosure, not a guarantee that no later financing occurred.

Sources · 1

Genesis Therapeutics Closes Oversubscribed $200 Million Series B ↗2026-10-22

Investors

a16z Bio + Health投资主体（类型未细分）Fidelity Management & Research Company投资主体（类型未细分）BlackRock资产管理 NVentures投资主体（类型未细分）T. Rowe Price资产管理 Rock Springs Capital投资主体（类型未细分）Radical Ventures风险投资 Menlo Ventures风险投资